Nearly three weeks after receiving the initial shipment of the COVID-19 vaccine, ThedaCare is in the final stages of vaccinating Phase 1a team members who are choosing to receive the vaccine.
On Jan. 13, ThedaCare President and CEO, Imran A. Andrabi, MD, FAAFP, received his first dose of the COVID-19 vaccine.